Fingerprint
Dive into the research topics where Avishay Sella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Outcomes by Retrospective Eligibility for Maintenance Therapy of Patients With Advanced Urothelial Carcinoma: Post Hoc Analysis of the Phase 3 KEYNOTE-361 Trial
Mamtani, R., Matsubara, N., Pino, A. M., Herranz, U. A., Şendur, M. A. N., Gravis, G., Huillard, O., Lee, H. J., Gafanov, R., Joly, F., Bedke, J., Sella, A., Chang, Y. H., Imai, K., Moreno, B. H., Xu, J. Z., Alva, A. & Powles, T., Feb 2025, In: Clinical Genitourinary Cancer. 23, 1, 102248.Research output: Contribution to journal › Article › peer-review
Open Access -
Editorial: Methods in genitourinary oncology
Jang, A., Sella, A., Nassar, A. H. & Koshkin, V. S., 2023, In: Frontiers in Oncology. 13, 1274264.Research output: Contribution to journal › Editorial
Open Access -
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
BLC2001 Study Group, Feb 2022, In: The Lancet Oncology. 23, 2, p. 248-258 11 p.Research output: Contribution to journal › Article › peer-review
Open Access163 Scopus citations -
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
GALAHAD investigators, Mar 2022, In: The Lancet Oncology. 23, 3, p. 362-373 12 p.Research output: Contribution to journal › Article › peer-review
Open Access185 Scopus citations -
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
KEYNOTE-361 Investigators, Jul 2021, In: The Lancet Oncology. 22, 7, p. 931-945 15 p.Research output: Contribution to journal › Article › peer-review
Open Access572 Scopus citations